Small Caps

678 Episodes

1. Invex Therapeutics (ASX: IXC) rolls-out Evolve phase III trial for drug Presendin in IIH patients (w/ Alex Sinclair)

   Published: 28/11/2022
2. Aston Minerals (ASX: ASO) eyes maiden nickel-cobalt resource for Bardwell discovery (w/ Dale Ginn)

   Published: 27/11/2022
3. 2023 will be a rollercoaster year, Bitcoin to $9k and gold to shine (w/ Gareth Soloway)

   Published: 26/11/2022
4. LiveHire (ASX: LVH) cements recruitment technology business in Australia-Pacific as US expansion accelerates (w/ Christy Forest)

   Published: 24/11/2022
5. Lotus Resources (ASX: LOT) looks to restart Kayelekera uranium mine as demand intensifies (w/ Keith Bowes)

   Published: 24/11/2022
6. Lode Resources (ASX: LDR) continues high-grade silver discovery success in New England Fold Belt (w/ Ted Leschke & Andrew Van Heyst)

   Published: 21/11/2022
7. Southern Cross Gold’s (ASX: SXG) Sunday Creek project continues to impress (w/ Michael Hudson)

   Published: 21/11/2022
8. Complii FinTech Solutions (ASX: CF1) achieves maiden profit, continues growth (w/ Craig Mason)

   Published: 20/11/2022
9. Uranium bull and the gold queen, as tech takes a beating (w/ Tony Locantro)

   Published: 09/11/2022
10. Emmerson Resources (ASX: ERM) makes ‘great progress’ across Tennant Creek copper-gold projects (w/ Rob Bills)

    Published: 07/11/2022
11. Orpheus Minerals (ASX: ORP) unveils IPO to pursue uranium exploration in Australia (w/ Simon Mitchell)

    Published: 07/11/2022
12. Latrobe Magnesium (ASX: LMG) advances magnesium production strategy in Australia and overseas (w/ David Paterson)

    Published: 31/10/2022
13. Challenging times ahead for investors but that's where opportunity resides (w/ Tony Locantro)

    Published: 25/10/2022
14. Echo IQ (ASX: EIQ) fast-tracks commercialisation of AI-based cardiovascular diagnostic tech (w/ Philip Woolff)

    Published: 24/10/2022
15. Galan Lithium (ASX: GLN) unveils ‘spectacular’ increase to flagship Hombre Muerto West lithium resource (w/ Juan Pablo Vargas de la Vega)

    Published: 24/10/2022
16. Vectus Biosystems (ASX: VBS) progresses its human trials with lead cardiovascular drug candidate VB0004 (w/ Maurie Stang)

    Published: 23/10/2022
17. Laramide Resources (ASX: LAM) bolsters clean energy transition with uranium assets across US and Australia (w/ Marc Henderson)

    Published: 20/10/2022
18. Greg Mannarino: global fiat currencies are in a race to the bottom

    Published: 18/10/2022
19. Boss Energy (ASX: BOE) targets first uranium from Honeymoon late next year to meet mounting demand (w/ Duncan Craib)

    Published: 13/10/2022
20. QMines (ASX: QML) continues drilling success at Mt Chalmers copper-gold project (w/ Andrew Sparke)

    Published: 13/10/2022